Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga lifescience sdn. bhd. - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 9v; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 19f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b -

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - diphtheria toxoid - injection - min 30 iu/0.5 ml

Canada - English - Health Canada

glaxosmithkline inc - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid; inactivated poliovirus type i; inactivated poliovirus type ii; inactivated poliovirus type iii - suspension - 25mcg; 25mcg; 8mcg; 30unit; 40unit; 40unit; 8unit; 32unit - pertussis toxoid 25mcg; filamentous haemagglutinin 25mcg; pertactin 8mcg; diphtheria toxoid 30unit; tetanus toxoid 40unit; inactivated poliovirus type i 40unit; inactivated poliovirus type ii 8unit; inactivated poliovirus type iii 32unit - vaccines

Canada - English - Health Canada

glaxosmithkline inc - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid; inactivated poliovirus type i; inactivated poliovirus type ii; inactivated poliovirus type iii; haemophilus influenzae type b-prp and tetanus toxoid conjugate (prp-t) - suspension - 25mcg; 25mcg; 8mcg; 30unit; 40unit; 40unit; 8unit; 32unit; 10mcg - pertussis toxoid 25mcg; filamentous haemagglutinin 25mcg; pertactin 8mcg; diphtheria toxoid 30unit; tetanus toxoid 40unit; inactivated poliovirus type i 40unit; inactivated poliovirus type ii 8unit; inactivated poliovirus type iii 32unit; haemophilus influenzae type b-prp and tetanus toxoid conjugate (prp-t) 10mcg - vaccines

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - poliovirus; pertactin; pertussis filamentous haemagglutinin; pertussis toxoid; diphtheria toxoid; hepatitis b surface antigen recombinant; tetanus toxoid -

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - diphtheria toxoid (d) - injection - min 30iu/0.5ml

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - diphtheria toxoid tetanus toxoid pertussis toxoid filamentous haemagglutinin (fha) pertactin - suspension for injection

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid 30 iu / 0.5 ml; filamentous haemogglutinin (fha) 25 mcg / 0.5 ml - suspension for injection - bacterial and viral vaccines, combined - this vaccine is indicated for booster vaccination against diphtheria, tetanus , pertussis, and poliomyelitis diseases in individuals from 16 months to 13 years of age inclusive.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - diphtheria toxoid - injection - 30 iu/0.5 ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - tetanus toxoid >= 40 iu/dose; bordetella pertussis toxoid (pt) 25 µg/dose; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; bordetella pertussis pertactin 8 µg/dose; diphtheria toxoid (dt) >= 30 iu/dose - suspension for injection in pre-filled syringe - diphteria toxoid, adsorbed; tetanus toxoid adsorbed; bordetella pertussis antigen, adsorbed - pertussis, purified antigen, combinations with toxoids